Get reviews centered on claims, experimental methods, reported results, limitations, and reproducibility criteria.Know what the science actually supports before you trust the answer.
Press Enter ↵ to request review
Explore by Goal
"I think it's much more interesting to live not knowing than to have answers which might be wrong."
This “update” review maps HSV-1 antagonism across PRRs → type I IFN induction → IFNAR/JAK–STAT → ISGs, emphasizing protein-specific mechanisms (e.g., US3/ICPO/TBK1/IRF3/IFI16/UL36USP) with a clear multi-step framework.
Biggest critique: it is largely a synthesis without a systematic coverage/quality appraisal, and several mechanistic claims are necessarily context- and model-dependent, especially where species/cell-type differences are known.
Long Explanation
Paper Review (IFN-I evasion focus): “Evasion of host antiviral innate immunity by HSV-1, an update”
Published online: March 08, 2016 • Authors: Chenhe Su, Guoqing Zhan, Chunfu Zheng • Journal: (journal shown in provided text) • DOI: 10.1186/s12985-016-0495-5
What the paper claims (mechanistic map)
The review organizes HSV-1 immune evasion as node-by-node interference with:
Type I IFN induction via PRRs (TLRs, RLRs, cytosolic DNA sensors)
STING–TBK1–IRF3 signaling and NF-κB activation
IFNAR/JAK–STAT/ISG deployment, where HSV-1 antagonizes multiple ISGs (e.g., UL41→viperin/ZAP/tetherin/others; PKR and OAS modulation)
Figure A — IFN-I pathway nodes targeted by HSV-1 (conceptual map)
The diagram is a structural abstraction of the review’s described pathway: PRRs → IFN-β induction → IFNAR signaling → ISG antiviral state, with HSV-1 proteins intervening at multiple steps.
Figure B — Evidence-strength reality check (review vs primary data)
The provided content is a review (“summarize the most recent findings”). Reviews can be accurate, but they also inherit selection bias and often compress model-specific observations into pathway-level conclusions. The review itself notes coverage is not exhaustive due to space.
Because no systematic quality rubric or numeric dataset is provided in the review text you supplied, this visualization is a schematic confidence gradient, not a formal meta-analysis.
Mechanistic anchors (examples) — where the review’s nodes are supported by specific primary studies
1) IFN induction shutdown via STING/TBK1/IRF3 axis
UL36USP deubiquitinase → TRAF3 antagonism: UL36USP inhibits IFN-β induction by deubiquitinating TRAF3, preventing TBK1 recruitment and depending on DUB activity (C40A abolishes the effect).
ICP34.5/TBK1 sequestration: the review notes HSV-1 ICP34.5 inhibits IFN production by binding/sequestering TBK1.
UL36USP → IFNAR2/JAK1-IFNAR2 blockade (alternative mechanism): a later primary study reports UL36USP binds IFNAR2 and blocks the interaction between JAK1 and IFNAR2, independently of its deubiquitinase activity, suppressing ISRE-driven transcription.
3) Cytosolic DNA sensing and IFI16 dynamics
IFI16 → IFN-β/IRF3 activation via acetylation-dependent relocalization: the review describes IFI16 acetylation redistributes it to the cytoplasm to interact with STING and induce IRF3 phosphorylation and IFN-β.
Species/cell-type and timing matter: even within the IFI16 node, later mechanistic complexity exists (e.g., stabilization effects vs degradation timing). The review’s “uncertain interactions” category and lack of exhaustive coverage means you should treat any single node as context-dependent until validated in your exact system.
4) Metabolic gating of DNA sensing: phosphate and glutamate (post-2016 updates)
DUX4–SLC34A2 → phosphate increases suppress innate immunity: a 2025 mBio study reports that herpesviruses activate a human-specific DUX4–SLC34A2 axis, raising intracellular phosphate to dampen antiviral innate signaling (including reduced TBK1/IRF3 phosphorylation) and showing rescue when phosphate is lowered or SLC34A2 is disrupted.
xCT/glutamate transport tunes cGAS-STING responses: a 2026 article links xCT-mediated glutamate export to cGAS-STING–dependent interferon responses to DNA and HSV-1, with HSV-1 ICP27 suppressing xCT to promote replication.
Why this matters for critiquing the 2016 review: the 2016 review frames immune evasion primarily as signaling node interference. These later studies show that metabolic state can be a decisive upstream regulator of DNA sensing/IFN output, expanding the conceptual landscape beyond the original node map.
Skeptical critique (what could mislead)
Non-systematic selection & omission risk: the authors state the review cannot be exhaustive due to space limits, meaning a reader can’t assume full coverage of contradicting results or negative findings.
Model dependence and cell-type/species gaps: the review spans TLR/RLR/cGAS-STING and multiple viral proteins, but many mechanistic details are demonstrated in specific cell lines or species contexts. Later work (e.g., DUX4–SLC34A2 human-specific axis) demonstrates that the same herpesviruses can behave very differently across species.
Node-level compression of multi-mechanism proteins: certain HSV proteins (notably UL36USP) appear capable of antagonizing IFN-I at multiple levels (TRAF3 deubiquitination vs IFNAR2/JAK-STAT interaction), and such pleiotropy can complicate causal attribution if only one mechanism is emphasized.
Over-generalization risk: the review is well-structured, but the field still has important “unknowns” (e.g., how HSV evades STING in detail; how HSV targets cGAS/STING vs timing of IFI16 relocalization). The review itself labels “uncertain interactions that need further study,” so confident causal language should be used carefully.
Figure C — Example HSV proteins mapped to IFN-I nodes (only where your provided sources support the link)
Mapped interactions are directly supported by the provided primary studies: UL36USP targets TRAF3 to block TBK1 recruitment (deubiquitinase-dependent in that study) and also disrupts IFNAR2–JAK1 interaction impacting ISRE-driven transcription (independent DUB activity in that separate study).
Overall assessment (skeptical but fair)
Strengths
Clear pathway-based organization that helps readers connect viral proteins to IFN-I induction and effector logic.
Multiple mechanistic examples are consistent with later primary mechanistic work provided here (e.g., UL36USP/TBK1-IRF3 and IFNAR-level effects; TRAF3 deubiquitination; IFI16 acetylation logic).
Weaknesses / known unknowns
As an update review, it lacks the methodological transparency of a systematic review (e.g., search strategy, inclusion/exclusion, quality weighting), and explicitly notes incomplete coverage.
The field’s understanding is expanding to include metabolic control upstream of PRR/DNA sensing outputs (phosphate and glutamate axes). This means the review’s signaling-node emphasis could underweight “upstream physiological state” determinants relative to newer work.
Further BGPT content: Author reviews for all authors in the provided paper
Uses BGPT’s raw-paper engine to extract additional, protein-by-protein IFN-I evasion evidence and identify contradictions/replication gaps across provided and newly indexed full texts.
Feedback:
Updated: July 11, 2026
BGPT Paper Review
Study Novelty
30%
The review primarily consolidates mechanistic knowledge of HSV-1 IFN-I evasion rather than introducing new experimental results; novelty is limited to narrative updates within an established pathway framework.
Scientific Quality
60%
Moderate-to-good scientific organization and mechanistic specificity (multiple named viral proteins and pathway nodes), but the provided material indicates non-systematic, space-limited coverage and no formal quality weighting of cited studies; thus causal generality and evidentiary strength vary by topic.
Study Generality
60%
The topic is broad within immunology/virology (innate sensing, IFN-I induction, ISGs), but it is specifically centered on HSV-1 and type I IFN nodes; generality is moderate rather than cross-pathogen universal.
Study Usefulness
70%
High as a pathway-oriented starting map for designing experiments targeting specific HSV–IFN nodes (e.g., PRRs, STING/TBK1/IRF3, NF-κB, IFNAR, ISGs), but lower as a decision tool because evidence weighting and coverage completeness are not guaranteed.
Study Reproducibility
20%
As a narrative review, it is not directly reproducible in the experimental sense; reproducibility depends on independently re-checking the primary studies and on the completeness/selection of citations (not provided as a systematic method).
Explanatory Depth
70%
Mechanistic explanations are fairly detailed for many nodes (naming specific HSV proteins and host targets), but depth is uneven because the manuscript is synthesis-based and marks some interactions as uncertain.
It will extract a node–protein interaction list from provided HSV-IFN evasion sources and generate a pathway adjacency table plus a ranked confidence summary based on which mechanisms are supported in primary studies.
Get emailed when your analysis is done!
We'll email you the results when your analysis is finished.
Hypothesis Graveyard
A simple “single-protein dominates” model (one HSV protein is the main IFN-I antagonist in all contexts) is unlikely because multiple independent primary studies support antagonism at distinct pathway levels (TRAF3/TBK1 and IFNAR2/JAK1), and host metabolic/state factors can change the dominant bottleneck.
A “species differences are minor” assumption is falsified by later evidence that herpesvirus activation of DUX4–SLC34A2 is human-specific and absent in murine cells under comparable conditions, implying that some evasion programs cannot be assumed to generalize.
Explore by Goal
Quick Explanation
Long Explanation
Top Data Sources
Ask a Follow-Up
Key Insight
Keep Exploring
Analysis 
Hypothesis Graveyard
Potential Experiments
Discussion